VarCov Co’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-13,926
Closed -$543K – 549
2026
Q2
$543K Sell
13,926
-2,114
-13% -$68.3K 0.21% 172
2026
Q1
$522K Buy
+16,040
New +$516K 0.19% 199

Other funds holding VKTX

VarCov Co's VKTX Position: Q3 2026 in Review

VarCov Co sold out of Viking Therapeutics (VKTX) in Q3 2026, closing a stake of 13,926 shares — an estimated $543K sold.

VarCov Co first reported a position in VKTX in Q1 2026 and held it in 2 quarters. The position peaked at $543K in Q2 2026. 444 funds tracked by Wall St. Rank hold VKTX as of Q3 2026.

  • VarCov Co reported no remaining Viking Therapeutics position as of Q3 2026 after selling out during the quarter.
  • VarCov Co sold 13,926 Viking Therapeutics shares in Q3 2026, an estimated $543K.
  • VarCov Co first reported a position in Viking Therapeutics in Q1 2026 and held it in 2 quarters.
  • VarCov Co's Viking Therapeutics position peaked at $543K in Q2 2026.
  • 444 funds tracked by Wall St. Rank held Viking Therapeutics as of Q3 2026.

Based on VarCov Co's 13F filing for Q3 2026, filed 16 Nov 2026.